Drug profile · INN
fluticasone propionate + salmeterol
SERETIDE MDI 250/25
fluticasone propionate + salmeterol (SERETIDE MDI 250/25) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — fluticasone propionate + salmeterol
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
fluticasone propionate + salmeterol (SERETIDE MDI 250/25) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is fluticasone propionate + salmeterol?
fluticasone propionate + salmeterol (SERETIDE MDI 250/25) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.
What is the brand name for fluticasone propionate + salmeterol?
SERETIDE MDI 250/25 is a marketed brand name for fluticasone propionate + salmeterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.